Olga Blomberg - Concepedia

Author

Olga Blomberg

The Netherlands Cancer Institute ORCID

Also Known As

O.S. Blomberg, Olga Blomberg, Olga S. Blomberg

Publications

973

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute Massachusetts General Hospital Dana-Farber Cancer Institute Boston Children's Hospital

About

Olga Blomberg is an author at The Netherlands Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	410
2	Immunology	3	3	345
3	Cell Biology	2	2	333
4	Natural Sciences	1	1	65
5	Molecular Biology	1	1	65

Olga Blomberg

Publications

826

Citations

H-Index

Page 1

	Year	Citations
IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer Olga Blomberg, Lorenzo Spagnuolo, Hannah Garner, Cancer Cell Cancer ImmunosurveillanceAutoimmune DiseaseImmunologyImmune Checkpoint InhibitorAutoimmunity	2022	192
Anti–CTLA-4 therapy requires an Fc domain for efficacy Jessica R. Ingram, Olga Blomberg, Mohammad Rashidian, Proceedings of the National Academy of Sciences ImmunologyImmunoeditingBiological TherapyPharmacotherapyImmunotherapeutics	2018	141
Localized CD47 blockade enhances immunotherapy for murine melanoma Jessica R. Ingram, Olga Blomberg, Jonathan T. Sockolosky, Proceedings of the National Academy of Sciences	2017	134
PD-L1 is an activation-independent marker of brown adipocytes Jessica R. Ingram, Michael Dougan, Mohammad Rashidian, Nature Communications	2017	122
Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs Michael Dougan, Jessica R. Ingram, Hee‐Jin Jeong, Cancer Immunology Research	2018	81
PrimPol prevents APOBEC/AID family mediated DNA mutagenesis Bas Pilzecker, Olimpia Alessandra Buoninfante, Colin E.J. Pritchard, Nucleic Acids Research Genome InstabilitySomatic VariantNatural SciencesGeneticsDna Mutagenesis	2016	65
Neoadjuvant immune checkpoint blockade triggers persistent and systemic T <sub>reg</sub> activation which blunts therapeutic efficacy against metastatic spread of breast tumors Olga Blomberg, Kevin Kos, Lorenzo Spagnuolo, OncoImmunology	2023	55
Dot1 histone methyltransferases share a distributive mechanism but have highly diverged catalytic properties I.J.E. Stulemeijer, Dirk De Vos, Kirsten van Harten, Scientific Reports	2015	24
LBA10 Critical role of eosinophils during response to immune checkpoint blockade in breast cancer and other cancer types Leonie Voorwerk, Hannah Garner, Olga Blomberg, Annals of Oncology Cancer ImmunosurveillanceImmunologyImmune Checkpoint InhibitorBreast CancerLba10 Critical Role	2020	12

Page 1